The Expansion Of The TRIPS-PLUS And The Countermeasure Of China

Economic development of the world become increasingly dependent on intellectual property rights.The United States and other developed countries tend to use their own dominant position in the international arena,the manipulation of the international intellectual property rules in an attempt to maximize their own interests.In addition to the TRIPS Agreement,developed countries also use a series of provisions of TRIPS-PLUS to continuously improve standards of intellectual property,to enable developing countries overwhelmed.Especially in the medical field of intellectual property,TRIPS-PLUS continuous expansion generated a lot of problems to society caused some negative effects.By studying TRIPS-PLUS in terms of Intellectual Property Rights,discusses causes and its impact,empirical analysis,to explore practical problems,and eventually settled into the status quo system in China,summarize coping strategies.Thesis consists of an introduction,body and conclusion of three parts,the text is divided into four parts:The first part,and pharmaceutical intellectual property rights related to the TRIPS-PLUS provisions related presentations.TRIPS-PLUS describes the terms and concepts analyzed under TRIPS-PLUS background,medical reasons for the expansion of intellectual property rights and their impact on international development trends and the intellectual property system for public health.The second part,the relevant examples by TRIPS-PLUS expansion affect the medical field of intellectual property analysis.Mainly elaborated Jordan and Australia to accept the status field of medicine TRIPS-PLUS after analysis of the impact of TRIPS-PLUS regard to medicines,health care costs,trade and investment,technology transfer and other produce.The third part of the key issues when the medical field of intellectual property TRIPS-PLUS expansion caused analyzed.In summary,based on the examples,focusing on TRIPS-PLUS of pharmaceutical patent term extension of the introduction of the patent system link,compulsory licensing and parallel import restrictions and strict pharmaceutical test data protection issues arising from,and analyze its real impact.The fourth part,our current intellectual property system and respond to recommendations.Introduction of the intellectual property system for the protection of the pharmaceutical section and pointed out its shortcomings,then according to our country,and put forward countermeasures system suggestions to improve our ability to respond to TRIPS-PLUS from international level and national level.